Literature DB >> 7929832

Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture.

L Wong1, G Yamasaki, R J Johnson, S L Friedman.   

Abstract

A consistent response to liver injury is the activation of resident mesenchymal cells known as lipocytes (Ito, fat-storing cells) into a proliferating cell type. In cultured lipocytes, platelet-derived growth factor (PDGF) is the most potent proliferative cytokine, but requires the activation-dependent expression of its receptor protein (Friedman, S. L., and M. J. P. Arthur. 1989. J. Clin. Invest. 84:1780-1785); the role of PDGF receptor (PDGFR) in liver injury is unknown. We have examined PDGFR gene expression in freshly isolated lipocytes during liver injury and correlated these findings with a culture model of cellular activation. Whereas lipocytes from normal rats had no detectable transcript for the beta-PDGFR subunit, this mRNA was induced within 1 h after a dose of carbon tetrachloride (CCl4). In contrast, alpha subunit mRNA was detected in normal cells, but was unchanged after liver injury. Similar results were observed in lipocytes from bile duct-obstructed rats, although beta-PDGFR induction was less marked. By immunoblot, induction of beta-PDGFR protein in lipocytes isolated from CCl4-treated animals correlated with mRNA increases. In contrast to lipocytes, endothelial cells from normal liver expressed low levels of alpha- and beta-receptor subunit mRNA, which did not increase with injury. Using a beta-PDGFR antibody, receptor protein could be identified within fibrotic septa in CCl4-treated animals in regions where cells expressed proliferating cell nuclear antigen (PCNA). In cultured lipocytes activated by growth on uncoated plastic, beta-PDGFR transcripts appeared within 3 d after plating, which coincided with the onset of cellular proliferation. In contrast, quiescent cells in suspension culture had no detectable beta-PDGFR mRNA. These results indicate that beta-PDGF receptor induction by lipocytes is an early event during hepatic injury in vivo and in primary culture.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929832      PMCID: PMC295310          DOI: 10.1172/JCI117497

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Differential expression of platelet-derived growth factor alpha- and beta- receptors on fat-storing cells and endothelial cells of rat liver.

Authors:  P Heldin; H Pertoft; H Nordlinder; C H Heldin; T C Laurent
Journal:  Exp Cell Res       Date:  1991-04       Impact factor: 3.905

2.  Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver.

Authors:  A Geerts; J M Lazou; P De Bleser; E Wisse
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

Review 3.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

4.  Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.

Authors:  D C Rockey; J K Boyles; G Gabbiani; S L Friedman
Journal:  J Submicrosc Cytol Pathol       Date:  1992-04

5.  Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans.

Authors:  C Reuterdahl; C Sundberg; K Rubin; K Funa; B Gerdin
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

6.  Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation.

Authors:  B H Davis; U R Rapp; N O Davidson
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

7.  In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury.

Authors:  J E Hines; S J Johnson; A D Burt
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

8.  Modulation of transforming growth factor beta receptors of rat lipocytes during the hepatic wound healing response. Enhanced binding and reduced gene expression accompany cellular activation in culture and in vivo.

Authors:  S L Friedman; G Yamasaki; L Wong
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Macrophage and perisinusoidal cell kinetics in acute liver injury.

Authors:  S J Johnson; J E Hines; A D Burt
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

10.  Expression of platelet-derived growth factor in a model of acute liver injury.

Authors:  M Pinzani; S Milani; C Grappone; F L Weber; P Gentilini; H E Abboud
Journal:  Hepatology       Date:  1994-03       Impact factor: 17.425

View more
  81 in total

1.  Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.

Authors:  Xu-Feng Zhang; Xinping Tan; Gang Zeng; Amalea Misse; Sucha Singh; Youngsoo Kim; James E Klaunig; Satdarshan P S Monga
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

2.  Novel insight into a platelet-derived growth factor-C/Smad3 axis in liver fibrosis. Focus on "Role of Smad3 in platelet-derived growth factor-C-induced liver fibrosis".

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  Am J Physiol Cell Physiol       Date:  2016-01-20       Impact factor: 4.249

Review 3.  Mechanisms of hepatic fibrogenesis.

Authors:  Ursula E Lee; Scott L Friedman
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-04       Impact factor: 3.043

4.  Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

5.  Precision-cut human liver slice cultures as an immunological platform.

Authors:  Xia Wu; Jessica B Roberto; Allison Knupp; Heidi L Kenerson; Camtu D Truong; Sebastian Y Yuen; Katherine J Brempelis; Marianne Tuefferd; Antony Chen; Helen Horton; Raymond S Yeung; Ian N Crispe
Journal:  J Immunol Methods       Date:  2018-02-01       Impact factor: 2.303

Review 6.  Mechanisms of hepatic fibrogenesis.

Authors:  Scott L Friedman
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

Review 7.  Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Authors:  Bhavna Rani; Yuan Cao; Andrea Malfettone; Ciprian Tomuleasa; Isabel Fabregat; Gianluigi Giannelli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 8.  Molecular mechanisms of hepatic fibrosis and principles of therapy.

Authors:  S L Friedman
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

Review 9.  Treatment of hepatic fibrosis: almost there.

Authors:  Efsevia Albanis; Rifaat Safadi; Scott L Friedman
Journal:  Curr Gastroenterol Rep       Date:  2003-02

Review 10.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.